260 related articles for article (PubMed ID: 19222368)
21. Regulatory T cells in patients with Whipple's disease.
Schinnerling K; Moos V; Geelhaar A; Allers K; Loddenkemper C; Friebel J; Conrad K; Kühl AA; Erben U; Schneider T
J Immunol; 2011 Oct; 187(8):4061-7. PubMed ID: 21918190
[TBL] [Abstract][Full Text] [Related]
22. Type I interferon induction is detrimental during infection with the Whipple's disease bacterium, Tropheryma whipplei.
Al Moussawi K; Ghigo E; Kalinke U; Alexopoulou L; Mege JL; Desnues B
PLoS Pathog; 2010 Jan; 6(1):e1000722. PubMed ID: 20090833
[TBL] [Abstract][Full Text] [Related]
23. Tropheryma whipplei, the Whipple's disease bacillus, induces macrophage apoptosis through the extrinsic pathway.
Gorvel L; Al Moussawi K; Ghigo E; Capo C; Mege JL; Desnues B
Cell Death Dis; 2010 Apr; 1(4):e34. PubMed ID: 21364641
[TBL] [Abstract][Full Text] [Related]
24. A case of Tropheryma whipplei infective endocarditis of the aortic and mitral valves in association with psoriatic arthritis and lumbar discitis.
Whistance RN; Elfarouki GW; Vohra HA; Livesey SA
J Heart Valve Dis; 2011 May; 20(3):353-6. PubMed ID: 21714430
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of pentamidine against Tropheryma whipplei.
Rolain JM; Fenollar F; Raoult D
Int J Antimicrob Agents; 2011 Dec; 38(6):545-7. PubMed ID: 22005072
[TBL] [Abstract][Full Text] [Related]
26. [Submucosal presentation of Whipple's disease: a variant that is easily missed].
Lynch MG; van den Berg-van Erp SH; Tan AC; Pettersson AM
Ned Tijdschr Geneeskd; 2012; 156(37):A4698. PubMed ID: 22971429
[TBL] [Abstract][Full Text] [Related]
27. Reduced peripheral and mucosal Tropheryma whipplei-specific Th1 response in patients with Whipple's disease.
Moos V; Kunkel D; Marth T; Feurle GE; LaScola B; Ignatius R; Zeitz M; Schneider T
J Immunol; 2006 Aug; 177(3):2015-22. PubMed ID: 16849516
[TBL] [Abstract][Full Text] [Related]
28. Changing paradigms in Whipple's disease and infection with Tropheryma whipplei.
Moos V; Schneider T
Eur J Clin Microbiol Infect Dis; 2011 Oct; 30(10):1151-8. PubMed ID: 21461659
[TBL] [Abstract][Full Text] [Related]
29. False positive PCR detection of Tropheryma whipplei in the saliva of healthy people.
Rolain JM; Fenollar F; Raoult D
BMC Microbiol; 2007 May; 7():48. PubMed ID: 17535423
[TBL] [Abstract][Full Text] [Related]
30. Whipple's disease and Tropheryma whipplei infections: from bench to bedside.
Boumaza A; Ben Azzouz E; Arrindell J; Lepidi H; Mezouar S; Desnues B
Lancet Infect Dis; 2022 Oct; 22(10):e280-e291. PubMed ID: 35427488
[TBL] [Abstract][Full Text] [Related]
31. Deadly carousel or difficult interpretation of new diagnostic tools for Whipple's disease: case report and review of the literature.
Müller SA; Vogt P; Altwegg M; Seebach JD
Infection; 2005 Feb; 33(1):39-42. PubMed ID: 15750760
[TBL] [Abstract][Full Text] [Related]
32. Whipple's disease: easily diagnosed, if considered.
Schijf LJ; Becx MC; de Bruin PC; van der Vegt SG
Neth J Med; 2008 Oct; 66(9):392-5. PubMed ID: 18931401
[TBL] [Abstract][Full Text] [Related]
33. Mucosal immune response to Tropheryma whipplei.
Ring S; Schneider T; Marth T
Int J Med Microbiol; 2003 Apr; 293(1):69-76. PubMed ID: 12755367
[TBL] [Abstract][Full Text] [Related]
34. Tropheryma whipplei , Immunosuppression and Whipple's Disease: From a Low-Pathogenic, Environmental Infectious Organism to a Rare, Multifaceted Inflammatory Complex.
Marth T
Dig Dis; 2015; 33(2):190-199. PubMed ID: 25925922
[TBL] [Abstract][Full Text] [Related]
35. Sewage workers with low antibody responses may be colonized successively by several Tropheryma whipplei strains.
Fenollar F; Marth T; Lagier JC; Angelakis E; Raoult D
Int J Infect Dis; 2015 Jun; 35():51-5. PubMed ID: 25910853
[TBL] [Abstract][Full Text] [Related]
36. Genotyping reveals a wide heterogeneity of Tropheryma whipplei.
Li W; Fenollar F; Rolain JM; Fournier PE; Feurle GE; Müller C; Moos V; Marth T; Altwegg M; Calligaris-Maibach RC; Schneider T; Biagi F; La Scola B; Raoult D
Microbiology (Reading); 2008 Feb; 154(Pt 2):521-527. PubMed ID: 18227256
[TBL] [Abstract][Full Text] [Related]
37. Immunosuppressive therapy in Whipple's disease patients is associated with the appearance of gastrointestinal manifestations.
Mahnel R; Kalt A; Ring S; Stallmach A; Strober W; Marth T
Am J Gastroenterol; 2005 May; 100(5):1167-73. PubMed ID: 15842595
[TBL] [Abstract][Full Text] [Related]
38. Tropheryma whipplei Increases Expression of Human Leukocyte Antigen-G on Monocytes to Reduce Tumor Necrosis Factor and Promote Bacterial Replication.
Ben Azzouz E; Boumaza A; Mezouar S; Bardou M; Carlini F; Picard C; Raoult D; Mège JL; Desnues B
Gastroenterology; 2018 Nov; 155(5):1553-1563. PubMed ID: 30076840
[TBL] [Abstract][Full Text] [Related]
39. Cultivation of Tropheryma whipplei from cerebrospinal fluid.
Maiwald M; von Herbay A; Fredricks DN; Ouverney CC; Kosek JC; Relman DA
J Infect Dis; 2003 Sep; 188(6):801-8. PubMed ID: 12964110
[TBL] [Abstract][Full Text] [Related]
40. Tropheryma whipplei infection and Whipple's disease.
Marth T; Moos V; Müller C; Biagi F; Schneider T
Lancet Infect Dis; 2016 Mar; 16(3):e13-22. PubMed ID: 26856775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
